Patents by Inventor Sven Schreder

Sven Schreder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable pharmaceutical preparation comprising levothyroxine sodium, gelatin and fillers and which is free of organic solvent residues
    Patent number: 8008349
    Abstract: The invention relates to a pharmaceutical preparation comprising levothyroxine sodium, gelatine and fillers, which is free of organic solvent residues.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: August 30, 2011
    Assignee: Merck Patent GmbH
    Inventors: Sven Schreder, Marion Nischwitz
  • Stable pharmaceutical formulation
    Publication number: 20050053651
    Abstract: The invention concerns a pharmaceutical composition in gelatine capsule form, comprising (a) an active core composition comprising at least one pharmaceutically active compound and optionally conventional pharmaceutical adjuvants, (b) at least one quenching protective layer, positioned between said active core composition and the inner surface of the gelatine capsule shell, which comprises at least one quenching agent, the quenching agent being able to chemically bind volatile impurities initiating the cross-linking of gelatine by a substantially irreversible chemical reaction after said impurities have been released by either adjuvants and/or active compound(s) of said active core composition and (c) a gelatine capsule shell wrapping said active core composition including any adjuvant material and any quenching layer added to the active core composition. Such a composition has improved stability on storage.
    Type: Application
    Filed: July 15, 2004
    Publication date: March 10, 2005
    Inventors: Armin Knapp, Sven Schreder
  • Pharmaceutical composition
    Publication number: 20040082600
    Abstract: The invention relates to a pharmaceutical composition having high bioavailability for oral administration of 4-[4-(3-chloro-4-methoxybenzyl-amino)benzo[4,5]thieno[2,3-d]pyrimidin-2-yl]cyclohexanecarboxylic acid and/or 4-[4-(3-chloro-4-hydroxybenzylamino)benzo[4,5]thieno[2,3-d]-pyrimidin-2-yl]cyclohexanecarboxylic acid or pharmaceutically acceptable salts thereof, to a process for the preparation of the pharmaceutical composition, and to the use thereof.
    Type: Application
    Filed: August 13, 2003
    Publication date: April 29, 2004
    Inventor: Sven Schreder
  • Pharmaceutical preparation
    Publication number: 20040063611
    Abstract: The invention relates to a pharmaceutical preparation comprising levothyroxine sodium, gelatine and fillers, which is free of organic solvent residues, and to processes for its production.
    Type: Application
    Filed: September 15, 2003
    Publication date: April 1, 2004
    Applicant: Merck Patent GmbH
    Inventors: Sven Schreder, Marion Nischwitz
  • Process for preparing a pharmaceutical formulation containing levothyroxine sodium
    Patent number: 6646007
    Abstract: The invention relates to a pharmaceutical preparation comprising levothyroxine sodium, gelatin and fillers, which is free of organic solvent residues.
    Type: Grant
    Filed: November 15, 2000
    Date of Patent: November 11, 2003
    Assignee: Merck Patent GmbH
    Inventors: Sven Schreder, Marion Nischwitz
  • Pharmaceutical levothyroxine preparation
    Patent number: 6491946
    Abstract: The invention relates to a pharmaceutical preparation comprising levothyroxine sodium, potassium iodide, microcrystalline cellulose and binding agent, which is free of antioxidants or further auxiliaries, and processes for its production.
    Type: Grant
    Filed: January 5, 2001
    Date of Patent: December 10, 2002
    Assignee: Merck Patent Gesellschaft
    Inventors: Sven Schreder, Marion Nischwitz